95 related articles for article (PubMed ID: 25927669)
1. A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.
Mulrane L; Gallagher WM; O'Connor DP
Breast Cancer Res; 2014 Nov; 16(6):467. PubMed ID: 25927669
[TBL] [Abstract][Full Text] [Related]
2. The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
Mol Cell; 2014 Mar; 53(5):806-18. PubMed ID: 24582497
[TBL] [Abstract][Full Text] [Related]
3. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
4. The function of EMSY in cancer development.
Hou J; Wang Z; Yang L; Guo X; Yang G
Tumour Biol; 2014 Jun; 35(6):5061-6. PubMed ID: 24609898
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.
Denis H; Van Grembergen O; Delatte B; Dedeurwaerder S; Putmans P; Calonne E; Rothé F; Sotiriou C; Fuks F; Deplus R
Mol Biosyst; 2016 Feb; 12(2):404-13. PubMed ID: 26621457
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.
Varier RA; Carrillo de Santa Pau E; van der Groep P; Lindeboom RG; Matarese F; Mensinga A; Smits AH; Edupuganti RR; Baltissen MP; Jansen PW; Ter Hoeve N; van Weely DR; Poser I; van Diest PJ; Stunnenberg HG; Vermeulen M
J Biol Chem; 2016 Apr; 291(14):7313-24. PubMed ID: 26841866
[TBL] [Abstract][Full Text] [Related]
7. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
8. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
[TBL] [Abstract][Full Text] [Related]
10. Expression of EMSY gene in sporadic ovarian cancer.
Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ
J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051
[TBL] [Abstract][Full Text] [Related]
13. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
14. EMSY, a BRCA-2 partner in crime.
Livingston DM
Nat Med; 2004 Feb; 10(2):127-8. PubMed ID: 14760417
[No Abstract] [Full Text] [Related]
15. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of CCND1 and EMSY in breast cancers.
Kirkegaard T; Nielsen KV; Jensen LB; Campbell FM; Müller S; Tovey SM; Brown S; Cooke TG; Bartlett JM
Histopathology; 2008 May; 52(6):698-705. PubMed ID: 18393977
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
20. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
